Warner C Greene

Title: Warner C Greene: Innovator in Interleukin-2 Receptor Research

Introduction

Warner C Greene is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of immunology, particularly in the study of interleukin-2 receptors. With a total of 2 patents, Greene's work has implications for diagnosing and understanding certain T-cell leukemias.

Latest Patents

Greene's latest patents include groundbreaking research on the human interleukin-2 receptor. The first patent focuses on cloning cDNAs for the human interleukin-2 receptor (55 RD protein). This cDNA has been produced and sequenced for the diagnosis of specific T-cell leukemias, especially those associated with the virus linked to adult T-cell leukemia. The second patent introduces a soluble interleukin-2 receptor as a disease indicator. This invention discloses a sandwich method and a kit for assaying interleukin-2 receptor (IL-2R) in a sample. The method involves determining the reactivity of the sample with various ligands, each having a unique binding affinity for specific sites on the receptor, distinct from the interleukin-2 binding site.

Career Highlights

Greene has had a distinguished career, contributing to significant advancements in medical research. His work has been pivotal in enhancing the understanding of interleukin-2 receptors and their role in human health.

Collaborations

Throughout his career, Greene has collaborated with esteemed colleagues, including Warren Jaye Leonard and David A Nelson. These collaborations have further enriched his research and innovations in the field.

Conclusion

Warner C Greene's contributions to the field of immunology through his patents on interleukin-2 receptors highlight his role as a leading inventor. His work not only advances scientific knowledge but also has the potential to improve diagnostic methods for T-cell leukemias.